Srb Corp Eli Lilly & CO Transaction History

Srb Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $2.09 Million - $2.58 Million	-9,445 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $393,237 - $508,650	2,178 Added 29.97%	9,445 $2.17 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $316,480 - $409,698	1,926 Added 36.06%	7,267 $1.36 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $196,342 - $259,808	1,505 Added 39.23%	5,341 $902,000
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $560,899 - $648,782	3,836 New	3,836 $567,000

4,256

756M

10.2M

11.4M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $824B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Srb Corp, based on Form 13F filings with the SEC.

Stay updated on Srb Corp with notifications on news.